Contract facts
NONEEO 14398 GGENOMIC MEDICINE RESEARCH is a federal NONE award for Rpo East (36C24E) held by Brigham & Womens Hospital Inc. Estimated value —.
Incumbent footprint
Public recordBrigham & Womens Hospital Inc — $20.7M obligated across 79 awards (firm-wide, all agencies) · lead buyer Department of Veterans Affairs (VA).
Related awards
Same incumbentQuery this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →
Frequently asked questions
What is contract 36C24E24D0016?
36C24E24D0016 (EO 14398 ggenomic medicine research) is a Rpo East (36C24E) award with an estimated value of —, currently held by Brigham & Womens Hospital Inc. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.
What is 36C24E-24-D-0016?
36C24E-24-D-0016 is the dashed form of PIID 36C24E24D0016 (EO 14398 ggenomic medicine research), held by Brigham & Womens Hospital Inc. Same award — SCOUT canonicalizes compact, dashed, and parent-child identifiers to one brief.
Which office awarded 36C24E24D0016?
Rpo East (36C24E) awarded 36C24E24D0016 to Brigham & Womens Hospital Inc.
Who is the incumbent on 36C24E24D0016?
Brigham & Womens Hospital Inc is the incumbent with $20.7M across 79 related awards in SCOUT’s public footprint.
When does Brigham & Womens Hospital Inc’s 36C24E24D0016 come up for recompete?
SCOUT tracks a period-of-performance end of an unstated date. Actual solicitation timing can shift with extensions, bridges, or consolidations.
Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.